WallStreetZenWallStreetZen

NASDAQ: AMRX
Amneal Pharmaceuticals Inc Stock Ownership - Who owns Amneal Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amneal Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
J. Kevin BuchiDirector2026-09-1120,445$14.45
$295.43kBuy
John KielyDirector2026-08-1350,000$17.64
$882.00kSell
Nikita ShahEVP2026-08-12146,403$17.51
$2.56MSell
Jason B. DalyCLO;EVP2026-08-12210,000$17.40
$3.65MSell
J. Kevin BuchiDirector2026-08-11168,573$17.18
$2.90MSell
Jason B. DalyCLO;EVP2026-08-116,613$17.70
$117.05kSell
Deborah M. AutorDirector2026-05-1134,819$12.94
$450.56kSell
Tasos KonidarisExecutive Vice President CFO2026-03-0422,035$13.30
$293.07kSell
Chintu PatelCo-CEO2026-03-0428,983$13.30
$385.47kSell
Andrew S. BoyerExecutive Vice President2026-03-0419,136$13.30
$254.51kSell

1 of 4

AMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMRX insiders and whales buy or sell their stock.

AMRX Shareholders

What type of owners hold Amneal Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tushar Bhikhubhai Patel67.97%217,076,305$4.37BInsider
Chintu Patel17.94%57,276,759$1.15BInsider
Chirag K. Patel15.75%50,314,044$1.01BInsider
Gautam Patel15.12%48,273,095$972.22MInsider
Dipan 1. Patel8.42%26,905,073$541.87MInsider
Dipan Patel8.42%26,905,073$541.87MInsider
Fosun International Ltd5.76%18,407,656$370.73MInsider
Ambient Impact Hk Ltd5.15%16,438,356$331.07MInsider
Tpg Group Holdings Sbs Advisors Inc5.08%16,213,367$326.54MInsider
Tpg GP A LLC3.86%12,328,767$248.30MInsider

1 of 3

AMRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMRX0.03%99.97%Net SellingNet Selling
LNTH0.11%99.89%Net SellingNet Selling
ALKS0.11%7.45%Net SellingNet Selling
LQDA0.08%77.81%Net SellingNet Selling
INDV0.10%4.36%Net SellingNet Buying
View Top Pharmaceutical Stocks

Amneal Pharmaceuticals Stock Ownership FAQ

Who owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals (NASDAQ: AMRX) is owned by 0.05% institutional shareholders, 154.91% Amneal Pharmaceuticals insiders, and 0.00% retail investors. Tushar Bhikhubhai Patel is the largest individual Amneal Pharmaceuticals shareholder, owning 217.08M shares representing 67.97% of the company. Tushar Bhikhubhai Patel's Amneal Pharmaceuticals shares are currently valued at $4.37B.

If you're new to stock investing, here's how to buy Amneal Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.